InMed Pharmaceuticals Inc.
INM | NASDAQ
$13.21
-$4.29 (-24.53%)
At close: Nov 5, 2026, 4:00 PM ET
$13.53
+$0.32 (+2.42%)
After-hours:
Nov 5, 2026, 4:28 PM ET
Fiscal Year Period Ending | FY 2026 Jun 30, 2026 | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | -0.50 | -0.39 | -0.25 | -0.29 | -0.01 | -1.69 |
PEG Ratio | 0.01 | 0.01 | 0 | 0 | 0 | 0.09 |
PS Ratio | 0 | 0.64 | 0.42 | 0.55 | 0.24 | n/a |
PB Ratio | 6 | 0.17 | 0.15 | 0.14 | 0.02 | 2.34 |
P/FCF Ratio | 0 | -0.41 | -0.27 | -0.30 | -0.02 | -2.18 |
P/OCF Ratio | 0 | -0.41 | -0.27 | -0.31 | -0.02 | -2.18 |
OCF/S Ratio | -272.11 | -157.14 | -151.94 | -176.11 | -1.43K | n/a |
Debt / Equity Ratio | n/a | 0.06 | 0.10 | 0.03 | 0.09 | 0.04 |
Quick Ratio | 1.37 | 6.47 | 3.78 | 4.86 | 2.14 | 3.78 |
Current Ratio | 1.37 | 6.99 | 4.41 | 5.66 | 2.89 | 3.78 |
Asset Turnover | 1.05K | 0.23 | 0.28 | 0.22 | 0.07 | n/a |
Interest Coverage | -924.78 | -21.22 | n/a | n/a | n/a | -33.78 |
Return on Equity | -1.17K% | -44.59% | -60.96% | -49.62% | -159.12% | -138.65% |
Return on Assets | -414.54% | -38.45% | -47.47% | -42.53% | -112.97% | -104.57% |
Return on Invested Capital | -920.47% | -41% | -58.49% | -50.67% | -108.50% | -128.71% |
Dividend Yield | 6.69K% | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | -3.44K% | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | -4.93% | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 22.35% | 34.53% | 23.94% | 33.93% | 49.89% | n/a |
Net Profit Margin | -0.40% | -165.14% | -166.94% | -192.18% | -1.71K% | n/a |
Pretax Profit Margin | -0.36% | -165.14% | -166.79% | -191.86% | -1.71K% | n/a |
Operating Profit Margin | -0.31% | -160.20% | -176.92% | -202.60% | -1.27K% | n/a |
FCF Margin | -272.11% | -157.14% | -152.14% | -180.02% | -1.43K% | n/a |
EBITDA Margin | -0.29% | -146.80% | -153.64% | -177.45% | -1.66K% | n/a |
Add to Watchlist
Select watchlists to add or remove INM